4//SEC Filing
Bandy Barton P. 4
Accession 0001235802-22-000091
CIK 0001427570other
Filed
Aug 10, 8:00 PM ET
Accepted
Aug 11, 4:15 PM ET
Size
5.0 KB
Accession
0001235802-22-000091
Insider Transaction Report
Form 4
Bandy Barton P.
DirectorPresident and CEO
Transactions
- Sale
Common Stock, $0.001 par value per share
2022-08-05$0.47/sh−11,674$5,487→ 773,098 total
Footnotes (1)
- [F1]On July 22, 2021, Mr. Bandy was awarded an aggregate of 1,186,006 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.
Documents
Issuer
ReShape Lifesciences Inc.
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001773309
Filing Metadata
- Form type
- 4
- Filed
- Aug 10, 8:00 PM ET
- Accepted
- Aug 11, 4:15 PM ET
- Size
- 5.0 KB